Skip to main content
Log in

Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer—a review focusing on open questions

  • Review
  • Published:
International Journal of Colorectal Disease Aims and scope Submit manuscript

Abstract

Background

The therapy of rectal cancer has been a matter of debate since decades, especially with regard to the benefits of neoadjuvant or adjuvant therapies. Principles of additional therapies have been established nearly two decades ago and are questioned nowadays on the basis of more recently modified operative techniques. Benefits and sequelae of therapies have to be balanced against each other, and it seems somewhat likely that a more differentiated strategy than simply stating that every patient with stage II and III rectal cancer needs chemoradiation or radiotherapy will, in long term, be recommended.

Conclusion

It should be kept in mind that results of centers of excellence and of phase-III studies with their positively selected patient populations are not representative for all the patients with rectal cancer and physicians treating them.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Camma C, Giunta M, Fiorica F, Pagliaro L, Craxi A, Cottone M (2000) Preoperative radiotherapy for resectable rectal cancer. A meta-analysis. JAMA 284:1008–1015

    PubMed  CAS  Google Scholar 

  2. Cedermark B, Johansson H, Rutqvist LE, Wilking N (1995) The Stockholm I trial of preoperative short term radiotherapy in operable rectal carcinoma: a prospective randomized trial. Cancer 75:2269–2275

    PubMed  CAS  Google Scholar 

  3. Gastrointestinal Tumor Study Group (1985) Prolongation of the disease free interval in surgically treated rectal carcinoma. N Engl J Med 312:1465–1472

    Article  Google Scholar 

  4. Kapiteijn E, Marijnen C, Colenbrander A, Klein Kranenbarg E, Steup W, van Krieken J, van Houwelingen J, Leer J, van de Velde C (1998) Local recurrence in patients with rectal cancer diagnosed between 1988 and 1992: a population-based study in the west Netherlands. Eur J Surg Oncol 24:528–535

    PubMed  CAS  Google Scholar 

  5. Krook J, Moertel C, Gunderson L, Wieand H, Collins R, Beart R, Kubista T, Poon M, Meyers W, Mailliard J, Twito D, Morton R, Veeder M, Witzig T, Cha S, Vidyarthi S (1991) Effective surgical adjuvant therapy for high risk rectal carcinoma. N Engl J Med 324:709–715

    Article  PubMed  CAS  Google Scholar 

  6. Swedish Rectal Cancer Trial Group (1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med 336:980–987 (Erratum (1997) N Engl J Med 336:1539)

    Google Scholar 

  7. Eriksen MT, Wibe A, Haffner J, Wiig JN, Norwegian Rectal Cancer Group (2007) Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy. Dis Colon Rectum 50:156–167

    PubMed  Google Scholar 

  8. Gunderson LL, Sargent DJ, Tepper JE, Wolmark N, O’Conell MJ, Begovic M, Allmer C, Colangelo L, Smalley SR, Haller DG, Martenson JA, Mayer RJ, Rich TA, Jaffer AA, MacDonald JS, Willet CG, Goldberg RM (2004) Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 22:1785–1796

    PubMed  Google Scholar 

  9. Dahl O, Horn A, Morild I, Halvorsen JF, Odland G, Reinertsen S, Reisaeter A, Kavli H, Thunold J (1990) Lowdose preoperative radiation postpones recurrences in operable rectal cancer: results of a randomized multicenter trial in western Norway. Cancer 66:2286–2294

    PubMed  CAS  Google Scholar 

  10. Gerard A, Buyse M, Nordlinger B, Loygue J, Pene F, Kempf P, Bosset JF, Gignoux M, Arnaud JP, Desaive C (1988) Preoperative radiotherapy as adjuvant treatment in rectal cancer: final results of a randomized study of the European Organization for Research and Treatment of Cancer (EORTC). Ann Surg 208:606–614

    Article  PubMed  CAS  Google Scholar 

  11. Goldberg PA, Nicholls RJ, Porter NH, Love S, Grimsey JE (1994) Long-term results of a randomised trial of short-course low dose adjuvant preoperative radiotherapy for rectal cancer: reduction in local treatment failure. Eur J Cancer 30:1602–1606

    Google Scholar 

  12. Marsh PJ, James RD, Schofield PF (1994) Adjuvant preoperative radiotherapy for locally advanced rectal carcinoma: results of a prospective, randomized trial. Dis Colon Rectum 37:1205–1214

    PubMed  CAS  Google Scholar 

  13. Medical Research Council Rectal Cancer Working Party (1996) Randomised trial of surgery alone versus radiotherapy followed by surgery for potentially operable locally advanced rectal cancer. Lancet 348:1605–1610

    Google Scholar 

  14. Reis Neto JA, Quilici FA, Reis JA Jr. (1989) A comparison of nonoperative vs. preoperative radiotherapy in rectal carcinoma: a 10-year randomized trial. Dis Colon Rectum 32:702–710

    PubMed  CAS  Google Scholar 

  15. Colorectal Cancer Collaborative Group (2001) Adjuvant radiotherapy for rectal cancer: a systematic overview of 8507 patients from 22 randomized trials. Lancet 358:1291–1304

    Google Scholar 

  16. NIH Consensus Conference (1990) Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444–1450

    Google Scholar 

  17. O’Connell M, Martenson J, Wieand H, Krook J, Macdonald J, Haller D, Mayer R, Gunderson L, Rich T (1994) Improving adjuvant therapy for rectal cancer by combining protracted-infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med 331:502–507

    PubMed  CAS  Google Scholar 

  18. Smalley SR, Benedetti JK, Williamson SK, Robertson JM, Estes NC, Maher T, Fisher B, Rich TA, Martenson JA, Kugler JW, Benson A, Haller DG, Mayer R, Atkins JN, Cripps C, Pedersen J, Periman PO, Tanaka MS Jr, Leichman CG, Macdonald JS (2006) Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 24:3542–3547

    PubMed  CAS  Google Scholar 

  19. Sauer R, Becker H, Hohenberger W, Rödel C, Wittekind C, Fietkau R, Martus P, Tschmelitsch J, Hager E, Hess CF, Karstens JH, Liersch T, Schmidberger H, Raab R, German Rectal Cancer Study Group (2004) Preoperative versus postoperative chemoradio-therapy for rectal cancer. N Engl J Med 351:1731–1740

    PubMed  CAS  Google Scholar 

  20. Chiappa A, Biffi R, Zbar AP, Luca F, Crotti C, Bertani E, Biella F, Zampino G, Orecchia R, Fazio N, Venturino M, Crosta C, Pruneri GC, Grassi C, Andreoni B (2005) Results of treatment of distal rectal carcinoma since the introduction of total mesorectal excision: a single unit experience, 1994–2003. Int J Colorectal Dis 20:221–230

    PubMed  Google Scholar 

  21. Heald RJ (1980) Towards fewer colostomies—the impact of circular stapling devices on the surgery of rectal cancer in a district hospital. Br J Surg 67:198–200

    PubMed  CAS  Google Scholar 

  22. Hermanek P (1999) Impact of surgeon’s technique on outcome after treatment of rectal carcinoma. Dis Colon Rectum 42:559–562

    PubMed  CAS  Google Scholar 

  23. Karanjia ND, Schache DJ, North WR, Heald RJ (1990) “Close shave” in anterior resection. Br J Surg 77:510–512

    PubMed  CAS  Google Scholar 

  24. MacFarlane J, Ryall R, Heald R (1993) Mesorectal excision for rectal cancer. Lancet 341:457–460

    PubMed  CAS  Google Scholar 

  25. Phillips RK, Hittinger R, Blesovsky L, Fry JS, Fielding LP (1984) Local recurrence following ‘curative’ surgery for large bowel cancer: I. The overall picture. Br J Surg 71:12–16

    PubMed  CAS  Google Scholar 

  26. Quirke P, Dixon M, Durdey P, Williams N (1986) Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumor spread and surgical excision. Lancet 2:996–999

    PubMed  CAS  Google Scholar 

  27. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B (2000) Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Lancet 356:93–96

    PubMed  CAS  Google Scholar 

  28. Martling A, Holm T, Rutqvist LE, Johansson H, Moran BJ, Heald RJ, Cedermark B (2005) Impact of a surgical training programme on rectal cancer outcomes in Stockholm. Br J Surg 92:225–229

    PubMed  CAS  Google Scholar 

  29. Wibe A, Möller B, Norstein J, Carlsen E, Wiig JN, Heald RJ, Langmark F, Myrvold HE, Soreide O, Norwegian Rectal Cancer Group (2002) A national strategic change in treatment policy for rectal cancer—implementation of total mesorectal excision as routine treatment in Norway. A national audit. Dis Colon Rectum 45:857–866

    PubMed  Google Scholar 

  30. Wibe A, Rendedal PR, Svensson E, Norstein J, Eide TJ, Myrvold HE, Soreide O (2002) Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 89:327–334

    PubMed  CAS  Google Scholar 

  31. Wolmark N, Wieand HS, Hyams DM, Colangelo L, Dimitrov NV, Romond EH, Wexler M, Prager D, Cruz AB Jr, Gordon PH, Petrelli NJ, Deutsch M, Mamounas E, Wickerham DL, Fisher ER, Rockette H, Fisher B (2000) Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 92:388–396

    PubMed  CAS  Google Scholar 

  32. Kapiteijn E, Marijnen CA, Nagtegaal ID, Putter H, Steup WH, Wiggers T, Rutten HJ, Pahlman L, Glimelius B, van Krieken JH, Leer JW, van de Velde CJ, Dutch Colorectal Cancer Group (2001) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 345:638–646

    PubMed  CAS  Google Scholar 

  33. Beets-Tan RG, Beets GL, Vliegen RF, Kessels AG, Van Boven H, De Bruine A, von Meyenfeldt MF, Baeten CG, van Engelshoven JM (2001) Accuracy of magnetic resonance imaging in prediction of tumour-free resection margin in rectal cancer surgery. Lancet. 357:497–504

    PubMed  CAS  Google Scholar 

  34. Ghadimi BM, Grade M, Difilippantonio MJ, Varma S, Simon R, Montagna C, Fuzesi L, Langer C, Becker H, Liersch T, Ried T (2005) Effectiveness of gene expression profiling for response prediction of rectal adenocarcinomas to preoperative chemoradiotherapy. J Clin Oncol 23:1826–1838

    PubMed  CAS  Google Scholar 

  35. Greene FL, Stewart AK, Norton HJ (2004) New tumor-node-metastasis staging strategy for node-positive (stage III) rectal cancer: an analysis. J Clin Oncol 22:1778–1784

    PubMed  Google Scholar 

  36. Junginger T, Hermanek P, Oberholzer K, Schmidberger H (2006) Rectal carcinoma: is too much neoadjuvant therapy performed? Proposals for a more selective MRI based indication. Zentralbl Chir 131:275–284

    PubMed  Google Scholar 

  37. Roeb E, Arndt M, Jansen B, Schumpelick V, Matern S (2004) Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas. Int J Colorectal Dis 19:518–524

    PubMed  Google Scholar 

  38. Hansen MH, Kiaeve J, Revhaug A, Eriksen MT, Wibe A, Vonen B, Norwegian Rectal Cancer Group (2007) Impact of radiotherapy on local recurrence of rectal cancer in Norway. Br J Surg 94:113–118

    PubMed  CAS  Google Scholar 

  39. Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ, Dotan ZA, Fearn PA, Kattan MW (2006) Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 98:715–717

    PubMed  Google Scholar 

  40. MERCURY Study Group (2007) Extramural depth of tumor invasion at thin-section MR in patients with rectal cancer: results of the MERCURY study. Radiology 243:132–139

    Google Scholar 

  41. Lippert H, Gastinger I (2006) Medical care of patients with rectal carcinoma in Germany. Dtsch Arztebl 103:A2704–2709

    Google Scholar 

  42. Sebag-Montefiore D, Steele R, Quirke P, Grieve R, Khanna S, Monson J, Holliday A, Thompson L, Griffiths G, Stephens R for the NCRI Colorectal Cancer Study Group and CR07 (2006) Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomised trial. Proc Am Soc Clin Oncol 2006:A3511

    Google Scholar 

  43. Quirke P, Sebag-Montefiore D, Steele R, Khanna S, Monson J, Holliday A, Thompson L, Griffiths G, Stephens R for the NCRI Colorectal Cancer Study Group and CR07 (2006) Local recurrence after rectal cancer resection is strongly related to the plane of surgical dissection and is further reduced by pre-operative short course radiotherapy. Preliminary results of the Medical Research Council (MRC) CR07 trial. Proc Am Soc Clin Oncol 2006:A3512

    Google Scholar 

  44. Fietkau R, Rödel C, Hohenberger W, Raab R, Hess C, Liersch T, Becker H, Wittekind C, Hutter M, Hager E, Karstens H, Ewald H, Christen N, Jagoditsch M, Martus P, Sauer R, German rectal cancer study group (2007) Rectal cancer delivery of radiotherapy in adequate time and with adequate dose is influenced by treatment center, treatment schedule, and gender and is prognostic parameter for local control: results of study CAO/ARO/AIO-94

  45. Glimelius B (2001) Pre- or postoperative radiotherapy in rectal cancer—more to learn? Radiother Oncol 61:1–5

    PubMed  CAS  Google Scholar 

  46. Ooi B, Tjandra J, Green M (1999) Morbidities of adjuvant chemotherapy and radiotherapy for respectable rectal cancer: an overview. Dis Colon Rectum 42:403–418

    PubMed  CAS  Google Scholar 

  47. Bosset JF, Colette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Ollier JC for the EORTC Radiotherapy Group Trial 2291 (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114–1123

    PubMed  CAS  Google Scholar 

  48. Gerard JP, Conroy T, Bonnetain F, Bouche O, Chapet O, Closon-Dejardin MT, Untereiner M, Leduc B, Francois E, Maurel J, Seitz JF, Buecher B, Mackiewicz R, Ducreux M, Bedenne L (2006) Preoperative radiotherapy with or without chemotherapy and leucovorin in T3–4 rectal cancers: results of FFCD 9203. J Clin Oncol 24:4620–4625

    PubMed  Google Scholar 

  49. Bosset JF, Calais G, Daban A, Berger C, Radosevic-Jelic L, Maingon P, Bardet E, Pierart M, Briffaux A, EORTC Radiotherapy Group (2004) Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance—report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer 40:219–224

    PubMed  CAS  Google Scholar 

  50. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Pudelko M, Kryj M, Oledzki J, Szmeja J, Sluszniak J, Serkies K, Kladny J, Pamucka M, Kukolowicz P (2004) Sphincter preservation following pre-operative radiotherapy for rectal cancer: report of a randomized trial comparing short-term radiotherapy vs conventionally fractionated radiochemotherapy. Radiother Oncol 72:15–24

    PubMed  CAS  Google Scholar 

  51. Bujko K, Nowacki MP, Nasierowska-Guttmejer A, Michalski W, Bebenek M, Kryi M for the Polish Colorectal Study Group (2006) Long term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215–1223

    PubMed  CAS  Google Scholar 

  52. Francois Y, Nemoz CJ, Baulieux J, Vignal J, Grandjean JP, Partensky C, Souquet JC, Adeleine P, Gerard JP (1999) Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer: the Lyon R90–01 randomized trial. J Clin Oncol 17:2396–2402

    PubMed  CAS  Google Scholar 

  53. Marijnen C, Kapiteijn E, van de Velde CJ, Martijn H, Steup WH, Wiggers T, Kranenbarg EK, Leer JW, Cooperative Investigators of the Dutch Colorectal Cancer Group (2002) Acute side effects and complications after shortterm preoperative radiotherapy combined with total mesorectal excision in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 20:817–826

    PubMed  CAS  Google Scholar 

  54. Marijnen CA, Nagtegaal ID, Klein Kranenbarg E, Hermans J, van de Velde CJ, Leer JW, van Krieken JH, Pathology Review Committee and the Cooperative Clinical Investigators (2001) No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J Clin Oncol 19:1976–1984

    PubMed  CAS  Google Scholar 

  55. Bosset JF, Calais G, Mineur L, Maigon P, Radosevic-Jelic L, Daban A, Bardet E, Beny A, Briffaux A, Collette L (2005) Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results—EORTC 22921. J Clin Oncol 23:5620–5627

    PubMed  CAS  Google Scholar 

  56. Klautke G, Küchenmeister U, Foitzik T, Ludwig K, Prall F, Klar E, Fietkau R (2006) Concurrent chemoradiation with capecitabine and weekly irinotecan as preoperative treatment for rectal cancer: results from a phase I/II study. Br J Cancer 94:976–981

    PubMed  CAS  Google Scholar 

  57. Rödel C, Grabenbauer GG, Papadopoulos T, Hohenberger W, Schmoll HJ, Sauer R (2003) Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J Clin Oncol 21:3098–3104

    PubMed  Google Scholar 

  58. Gerard JP, Chapet O, Nemoz C, Romestaing P, Mornex F, Coquard R, Barbet N, Atlan D, Adeleine P, Freyer G (2003) Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial. J Clin Oncol. 21:1119–1124

    PubMed  Google Scholar 

  59. Crane CH, Skibber JM, Birnbaum EH, Feig BW, Singh AK, Delclos ME, Lin EH, Fleshman JW, Thames HD, Kodner IJ, Lockett MA, Picus J, Phan T, Chandra A, Janjan NA, Read TE, Myerson RJ (2003) The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced rectal cancer. Int J Radiat Oncol Biol Phys 57:84–89

    PubMed  CAS  Google Scholar 

  60. Janjan NA, Crane C, Feig BW, Cleary K, Dubrow R, Curley S, Vauthey JN, Lynch P, Ellis LM, Wolff R, Lenzi R, Abbruzzese J, Pazdur R, Hoff PM, Allen P, Brown T, Skibber J (2001) Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer. Am J Clin Oncol 24:107–112

    PubMed  CAS  Google Scholar 

  61. Valentini V, Coco C, Cellini N, Picciocchi A, Rosetto ME, Mantini G, Marmiroli L, Barbaro B, Cogliandolo S, Nuzzo G, Tedesco M, Ambesi-Impiombato F, Cosimelli M, Rotman M (1999) Preoperative chemoradiation with cisplatin and 5-fluorouracil for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, sphincter preservation. Int J Radiat Oncol Biol Phys 45:1175–1184

    PubMed  CAS  Google Scholar 

  62. Hartley A, Ho KF, McConkey C, Geh JI (2005) Pathological complete response following pre-operative chemoradiotherapy in rectal cancer: analysis of phase II/III trials. Br J Radiol 78:934–938

    PubMed  CAS  Google Scholar 

  63. Glynne-Jones R, Anyamene N (2006) Just how useful an endpoint is complete pathological response after neoadjuvant chemoradiation in rectal cancer? Int J Radiat Oncol Biol Phys 66:319–320

    PubMed  Google Scholar 

  64. Hermanek P, Hermanek P, Hohenberger W, Klimpfinger M, Kockerling F, Papadopoulos T (2003) The pathological assessment of mesorectal excision: implications for further treatment and quality management. Int J Colorectal Dis 18:335–341

    PubMed  CAS  Google Scholar 

  65. Hiotis SP, Weber SM, Cohen AM, Minsky BD, Paty PB, Guillem JG, Wagman R, Saltz LB, Wong WD (2002) Assessing the predictive value of clinical complete response to neoadjuvant therapy for rectal cancer: an analysis of 488 patients. J Am Coll Surg 194:131–136

    PubMed  Google Scholar 

  66. Dworak O, Keilholz L, Hoffmann A (1997) Pathological features of rectal cancer after preoperative radiochemotherapy. Int J Colorectal Dis 12:19–23

    PubMed  CAS  Google Scholar 

  67. Rödel C, Martus P, Papadoupolos T, Fuzesi L, Klimpfinger M, Fietkau R, Liersch T, Hohenberger W, Raab R, Sauer R, Wittekind C (2005) Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 23:8688–8696

    PubMed  Google Scholar 

  68. Fietkau R, Barten M, Klautke G, Klar E, Ludwig K, Thomas H, Brinckmann W, Friedrich A, Prall F, Hartung G, Kuchenmeister U, Kundt G (2006) Postoperative chemotherapy may not be necessary for patients with ypN0-category after neoadjuvant chemoradiotherapy of rectal cancer. Dis Colon Rectum 49:1284–1292

    PubMed  Google Scholar 

  69. Collette L, Bosset JF, den Dulk M, Nguyen F, Mineur L, Maignon P, Radosevic-Jelic L, Pierart M, Calais G (2007) Patients with curative resections of cT3–4 rectal cancer after preoperative radiotherapy or radiochemotherapy: does anybody benefit from adjuvant fluorouracil based chemotherapy? A trial of the European organisation for research and treatment of cancer radiation oncology group. J Clin Oncol 25:4379–4386

    PubMed  CAS  Google Scholar 

  70. Rasheed S, Guenther T, Talbot I, McDonald P, Northover J, Stirling J, Culver L, Glynne- Jones R, Padhani AR (2006) USPIO—enhanced rectal cancer specimen MRI: how well does it correlate with node identification at histopathology? Colorectal Dis 8:721

    Google Scholar 

  71. Chau I, Brown G, Cunningham D, Tait D, Wotherspoon A, Norman AR, Tebbutt N, Hill M, Ross PJ, Massey A, Oates J (2006) Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J Clin Oncol 24:668–674

    PubMed  CAS  Google Scholar 

  72. Glynne-Jones R, Grainger J, Harrison M, Ostler P, Makris A (2006) Neoadjuvant chemotherapy prior to preoperative chemoradiation or radiation in rectal cancer: should we be more cautious? Br J Cancer 94:363–371

    PubMed  CAS  Google Scholar 

  73. Bujko K, Kepka L, Michalski W, Nowacki MP (2006) Does rectal cancer shrinkage induced by pre-operative radio (chemo)therapy increase the likelihood of anterior resection? A systematic review of randomized trials. Radiother Oncol 80:4–12

    PubMed  Google Scholar 

  74. Crane CH, Skibber JM, Feig BW, Vauthey JN, Thames HD, Curley SA, Rodriguez-Bigas MA, Wolff RA, Ellis LM, Delclos ME, Lin EH, Janjan NA (2003) Response to preoperative chemo-radiation increases the use of sphincter preserving surgery in patients with locally advanced low rectal carcinoma. Cancer 97:517–524

    PubMed  Google Scholar 

  75. Hohenberger W, Merkel S, Matzel K, Bittorf B, Papadopoulos T Gohl J (2006) The influence of abdomino-peranal (intersphincteric) resection of lower third rectal carcinoma on the rates of sphincter preservation and locoregional recurrence. Colorectal Dis 8:23–33

    PubMed  CAS  Google Scholar 

  76. Grann A, Feng C, Wong D, Saltz L, Paty PP, Guillem JG, Cohen AM, Minsky BD (2001) Pre-operative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int J Radiat Oncol Biol Phys 49:987–995

    PubMed  CAS  Google Scholar 

  77. Hyams DM, Mamounas EP, Petrelli N, Rockette H, Jones J, Wieand HS, Deutsch M, Wickerham L, Fisher B, Wolmark N (1997) A clinical trial to evaluate the worth of pre- operative multi-modality therapy in patients with operable carcinoma of the rectum. A progress report of National Surgical Adjuvant Breast and bowel Project Protocol R-03. Dis Colon Rectum 40:131–139

    PubMed  CAS  Google Scholar 

  78. Marijnen CA, Nagtegaal ID, Kapiteijn E, Kranenbarg EK, Noordijk EM, van Krieken JH, van de Velde CJ, Leer JW, Cooperative Investigators of the Dutch Colerectal Cancer Group (2003) Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 55:1311–1320

    PubMed  CAS  Google Scholar 

  79. Bosset JF (2006) Distal rectal cancer: sphincter-sparing is also a challenge for the radiation oncologist. Radiother Oncol 80:1–3

    PubMed  Google Scholar 

  80. Moore HG, Riedel E, Minksy BD, Saltz L, Paty P, Wong D, Cohen AM, Guillem JG (2003) Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann Surg Oncol 10:80–85

    PubMed  Google Scholar 

  81. Rullier E, Laurent C, Bretagnol F, Rullier A, Vendrely V, Zerbib F (2005) Sphincter-saving resection for all rectal carcinomas. The end of the 2-cm distal rule. Ann Surg 241(3):465–469

    PubMed  Google Scholar 

  82. Shirouzu K, Isomoto H, Kakegawa T (1995) Distal spread of rectal cancer and optimal distal margin of resection for sphincterpreserving surgery. Cancer 76:388–392

    PubMed  CAS  Google Scholar 

  83. Valentini V, Glimelius B, Minsky BD, Van Cutsem E, Bartelink H, Beets-Tan RG, Gerard JP, Kosmidis P, Pahlman L, Picciocchi A, Quirke P, Tepper J, Tonato M, Van de Velde CJ, Cellini N, Latini P (2005) The multidisciplinary rectal cancer treatment: main convergences, controversial aspects and investigational areas which support the need for an European Consensus. Radiother Oncol 76:241–250

    PubMed  Google Scholar 

  84. Wang Z, Zhou Z, Wang C, Zhao G, Chen Y, Gao H, Zheng X, Wang R, Chen D (2005) Microscopic spread of low rectal cancer in regions of the mesorectum: detailed pathological assessment with whole-mount sections. Int J Colorectal Dis 20:231–237

    PubMed  CAS  Google Scholar 

  85. Williams NS, Dixon MF, Johnston D (1983) Reappraisal of the 5 centimetre rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients’ survival. Br J Surg 70:150–154

    PubMed  CAS  Google Scholar 

  86. Galandiuk S, Wieand HS, Moertel CG, Cha SS, Fitzgibbons RJ, Pemberton JH, Wolff BG (1992) Patterns of recurrence after curative resection of carcinoma of the colon and rectum. Surg Gynecol Obstet 174:27–32

    PubMed  CAS  Google Scholar 

  87. Gunderson L, Sosin H (1974) Areas of failure found at reoperation (second or symptomatic look) following “curative surgery” for adenocarcinoma of the rectum: clinicopathologic correlation and implications for adjuvant therapy. Cancer 34:1278–1292

    PubMed  CAS  Google Scholar 

  88. Höcht S, Mann B, Germer CT, Siegmann A, Wiegel T, Buhr HJ, Hinkelbein W (2004) Pelvic sidewall involvement in recurrent rectal cancer. Int J Colorectal Dis 19:108–113

    PubMed  Google Scholar 

  89. Hruby G, Barton M, Miles S, Carroll S, Nasser E, Stevens G (2003) Sites of local recurrence after surgery, with or without chemotherapy, for rectal cancer: implications for radiotherapy field design. Int J Radiat Oncol Biol Phys 55:138–143

    PubMed  Google Scholar 

  90. Minsky BD, Mies C, Recht A, Rich TA, Chaffey JT (1998) Resectable adenocarcinoma of the rectosigmoid and rectum. I. Patterns of failure and survival. Cancer 61:1408–1416

    Google Scholar 

  91. Pilipshen S, Heilweil M, Quan S, Sternberg S, Enker W (1984) Patterns of pelvic recurrence following definitive resections of rectal cancer. Cancer 53:1354–1362

    PubMed  CAS  Google Scholar 

  92. Roels S, Duthoy W, Haustermans K, Penninckx F, Vandecaveye V, Boterberg T, De Neve W (2006) Definition and delineation of the clinical target volume for rectal cancer. Int J Radiat Oncol Biol Phys 65:1129–1142

    PubMed  Google Scholar 

  93. Baglan K, Frazier R, Yan D, Huang R, Martinez A, Robertson J (2002) The dose–volume relationship of acute small bowel toxicity from concurrent 5-FU-based chemotherapy and radiation therapy for rectal cancer. Int J Radiat Oncol Biol Phys 52:176–183

    PubMed  Google Scholar 

  94. Letschert J, Lebesque J, Aleman B, Bosset J, Horiot J, Bartelink H, Cionini L, Hamers J, Leer J, van Glabbeke M (1994) The volume effect in radiation related small-bowel complications: results of a clinical study of the EORTC Radiotherapy Cooperative Group in patients treated for rectal cancer. Radiother Oncol 32:116–123

    PubMed  CAS  Google Scholar 

  95. Minsky BD, Conti J, Huang Y, Knopf K (1995) Relationship of acute gastrointestinal toxicity and volume of irradiated small bowel in patients receiving combined modality therapy for rectal cancer. J Clin Oncol 13:1409–1416

    PubMed  CAS  Google Scholar 

  96. Sauer R, Fietkau R, Wittekind C Martus P, Rödel C, Hohenberger W, Jatzko G, Sabitzer H, Karstens JH, Becker H, Hess C, Raab R (2001) Adjuvant versus neoadjuvant radiochemotherapy for locally advanced rectal cancer: a progress report of a phase-III randomized trial (protocol CAO/ARO/AIO-94). Strahlenther Onkol 177:173–181

    PubMed  CAS  Google Scholar 

  97. Koda K, Saito N, Oda K, Takiguchi N, Sarashina H, Miyazaki M (2004) Evaluation of lateral lymph node dissection with preoperative chemo-radiotherapy for the treatment of advanced middle and lower rectal cancers. Int J Colorect Dis 19:188–194

    CAS  Google Scholar 

  98. Kim JY, Kim DY, Kim TH, Park SY, Lee SB, Shin KH, Pyo H, Kim JY, Cho KH (2007) Intensity-modulated radiotherapy with a belly board for rectal cancer. Int J Colorect Dis 22:373–379

    Google Scholar 

  99. Peeters KCMJ, van de Velde CJH, Leer JWH, Martijn H, Junggeburt JM, Kranenbarg EK, Steup WH, Wiggers T, Rutten HJ, Marijnen CA (2005) Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients—a Dutch colorectal cancer group study. J Clin Oncol 23:6199–6206

    PubMed  CAS  Google Scholar 

  100. Pietrzak L, Bujko K, Nowacki MP, Kepka L, Oledzki J, Rutkowski A, Szmeja J, Kladny J, Dymecki D, Wieczorek A, Pawlak M, Lesniak T, Kowalska T, Richter P, on behalf of the Polish Colorectal Study Group (2007) Quality of life, anorectal and sexual functions after preoperative radiotherapy for rectal cancer: report of a randomized trial. Radiother Oncol 84:217–225

    PubMed  Google Scholar 

  101. Dahlberg M, Glimelius B, Graf W, Pahlman L (1998) Pre-operative irradiation affects functional results after surgery for rectal cancer. Dis Colon Rectum 41:543–551

    PubMed  CAS  Google Scholar 

  102. Gervaz P, Rotholtz N, Pisano M, Kaplan E, Secic M, Coucke P, Pikarsky A, Efron J, Weiss E, Wexner S (2001) Quantitative short-term study of anal sphincter function after chemoradiation for rectal cancer. Arch Surg 136:192–196

    PubMed  CAS  Google Scholar 

  103. Nathanson D, Espat N, Nash G, D'Alessio M, Thaler H, Minsky BD, Enker W, Wong D, Guillem J, Cohen A, Paty P (2003) Evaluation of preoperative and postoperative radiotherapy on longterm functional results of straight coloanal anastomosis. Dis Colon Rectum 46:888–894

    PubMed  Google Scholar 

  104. Rouanet P, Saint-Aubert B, Lemanski C, Senesse P, Gourgou S, Quenet F, Ycholu M, Kramar A, Dubois J (2002) Restorative and nonrestorative surgery for low rectal cancer after high-dose radiation. Long-term oncologic and functional results. Dis Colon Rectum 45:305–315

    PubMed  Google Scholar 

  105. Rullier E, Goffre B, Bonnel C, Zerbib F, Caudry M, Saric J (2001) Preoperative radiochemo-therapy and sphincter-saving resection for T3 carcinomas of the lower third of the rectum. Ann Surg 234:633–640

    PubMed  CAS  Google Scholar 

  106. Guckenberger M, Flentje M (2006) Late small bowel toxicity after adjuvant treatment for rectal cancer. Int J Colorect Dis 21:209–220

    Google Scholar 

  107. Bakx R, Sprangers MA, Oort FJ, van Tets WF, Bemelman WA, Slors JF, van Lanschot JJ (2005) Development and validation of a colorectal functional outcome questionnaire. Int J Colorectal Dis 20:126–136

    PubMed  Google Scholar 

  108. Pietsch AP, Fietkau R, Klautke G, Foitzik T, Klar E (2007) Effect of neoadjuvant chemoradiation on postoperative fecal continence and anal sphincter function in rectal cancer patients. Int J Colorect Dis 22:1311–1317

    Google Scholar 

  109. Chorost M, Weber T, Lee R, Rodriguez-Bigas MA, Petrelli NJ (2000) Sexual dysfunction, informed consent and multimodality therapy for rectal cancer. Am J Surg 179:271–274

    PubMed  CAS  Google Scholar 

  110. Guren MG, Eriksen MT, Wiig JN, Carlsen E, Nesbakken A, Sigurdsson HK, Wibe A, Tveit KM, Norwegian Rectal Cancer Group (2005) Quality of life and functional outcome following anterior or abdominoperineal resection for rectal cancer. Eur J Surg Oncol 31:735–742

    PubMed  CAS  Google Scholar 

  111. Mannaerts G, Schijven M, Hendrikx A, Martijn H, Rutten HJ, Wiggers T (2001) Urologic and sexual morbidity following multimodality treatment for locally advanced primary and locally recurrent rectal cancer. Eur J Surg Oncol 27:265–272

    PubMed  CAS  Google Scholar 

  112. Marijnen CA, van de Velde CJ, Putter H, van den Brink M, Maas CP, Martijn H, Rutten HJ, Wiggers T, Kranenbarg EK, Leer JW, Stiggelbout AM (2005) Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol 23:1847–1858

    PubMed  Google Scholar 

  113. Temple L, Wong W, Minsky B (2003) The impact of radiation on functional outcomes in patients with rectal cancer and sphincter preservation. Semin Radiat Oncol 13:469–477

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Stefan Höcht.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moser, L., Ritz, JP., Hinkelbein, W. et al. Adjuvant and neoadjuvant chemoradiation or radiotherapy in rectal cancer—a review focusing on open questions. Int J Colorectal Dis 23, 227–236 (2008). https://doi.org/10.1007/s00384-007-0419-3

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00384-007-0419-3

Keywords

Navigation